Melinta Therapeutics and Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity against Complicated Urinary Tract Infection Pathogens
September 06, 2014 12:01 ET
|
Melinta Therapeutics
NEW HAVEN, Conn, Sept. 6, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics and
Hartford Hospital today announced in vitro results from an
investigator-sponsored study that highlight delafloxacin's...